Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 2—February 2025
Dispatch

Diphtheria Toxin–Producing Corynebacterium ramonii in Inner-City Population, Vancouver, British Columbia, Canada, 2019–2023

Christopher F. Lowe1Comments to Author , Gordon Ritchie1, Chiara Crestani, Miguel Imperial, Nancy Matic, Michael Payne, Aleksandra Stefanovic, Diana Whellams, Sylvain Brisse2, and Marc G. Romney2
Author affiliation: Author affiliations: University of British Columbia, Vancouver, British Columbia, Canada (C.F. Lowe, G. Ritchie, M. Imperial, N. Matic, M. Payne, A. Stefanovic, D. Whellams, M.G. Romney); St. Paul’s Hospital, Vancouver (C.F. Lowe, G. Ritchie, N. Matic, M. Payne, A. Stefanovic, M.G. Romney); Institut Pasteur–Université Paris Cité, Paris, France (C. Crestani, S. Brisse); LifeLabs, Vancouver (M. Imperial, D. Whellams); Institut Pasteur National Reference Center for Corynebacteria of the Diphtheriae Complex, Paris (S. Brisse)

Main Article

Table

Antimicrobial drug susceptibility, co-isolated bacteria, and toxin test results for wound specimens containing Corynebacterium ulcerans and C. ramonii collected in Vancouver, British Columbia, Canada, 2019–2023*

Characteristics Corynebacterium ulcerans, n = 6 Corynebacterium ramonii, n = 8
Antimicrobial drug susceptibility
Penicillin NA Intermediate, n = 8
Erythromycin NA Susceptible, n = 8
Clindamycin NA Susceptible, n = 1; intermediate, n = 7
Vancomycin
NA
Susceptible, n = 8
Frequency of co-isolated bacteria from wound cultures
Enterobacterales, n = 4; MSSA, n = 3; coagulase-negative staphylococci,† n = 2; β-hemolytic Streptococcus,‡ n = 2; Acinetobacter baumannii, n = 1
β-hemolytic Streptococcus,§ n = 6; Arcanobacterium hemolyticum, n = 4; MSSA, n = 4; Enterobacterales, n = 3; yeast, n = 1; Pasteurella multocida, n = 1
Toxin testing, no. (%) isolates
Nontoxigenic 4 (66.6) 4 (50.0)
Nontoxigenic, tox gene–bearing 0 1 (12.5)
Toxigenic 2 (33.3) 3 (37.5)

*Bacteria were isolated from wounds on lower extremities of patients. MSSA, methicillin-susceptible Staphylococcus aureus; NA, not applicable. †Staphylococcus pseudintermedius, S. lugdunensis. ‡Streptococcus dysgalactiae and group G Streptococcus. §Streptococcus pyogenes, S. dysgalactiae subspecies equisimilis.

Main Article

1These first authors contributed equally to this article.

2These senior authors contributed equally to this article.

Page created: December 30, 2024
Page updated: January 07, 2025
Page reviewed: January 07, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external